At last, the state of Indiana put out a useful tweet: People with weakened immune systems are at greater risk if diagnosed with #COVID19 , but there are treatments that can help prevent serious illness. Learn more at http://tinyurl.com/C19treatment The link goes to the state's page on COVID treatment, which includes the monoclonal antibody Sotrovimab . It's available, has emergency use authorization and effective against Omicron. The clinical trial participants were at high risk of COVID progression due to age, obesity, diabetes and other risk factors. This was a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. From the study : In this prespecified interim analysis, which included an intention-to-treat population of 583 patients (291 in the sotrovimab group and 292 in the placebo group), 3 patients (1%) in the sotrovimab group, as compared with 21 patients (7%) in the placebo group, had disease progression leading to hospitalization or death ( relati
Do-it-yourself health. Low-carb, mostly evolutionary.